![]() |
市场调查报告书
商品编码
1930064
全球眼科诊断设备市场:市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测(2025-2034)Ophthalmic Diagnostic Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
预计2025年全球眼科诊断设备市场规模将达27.2亿美元,2026年将成长至28.9亿美元,到2034年将达到48.2亿美元,预测期内复合年增长率(CAGR)为6.60%。北美地区将在2025年占市场主导地位,市场占有率将达到38.20%,这主要得益于该地区较高的眼科手术量、技术应用以及新产品的推出。市场上的主要参与者包括卡尔蔡司医疗技术股份公司 (Carl Zeiss Meditec AG)、拓普康公司 (Topcon Corporation)、尼得克株式会社 (Nidek Co., Ltd.)、爱尔康 (Alcon)、依视路陆逊梯卡集团 (EssilorLuxottica)、佳能医疗系统 (Canon Medical Systems)、Mon Medical Systems Corporation (Zomb Systems)、佳能医疗系统公司 (Zon Medical Systems)、Mon Ophthalmic Systems AG)、哈格-斯特雷特集团 (Haag-Streit Group) 和 Visionix。这些公司正致力于技术创新、策略联盟和全球扩张,以巩固其市场地位。
眼科诊断设备包括光学相干断层扫描 (OCT)、像差仪地形图系统、眼底照相机、眼科超音波设备、裂隙灯、检眼镜和眼压计。这些设备用于检测、诊断和监测青光眼、糖尿病视网膜病变、老年黄斑部病变、白内障、屈光不正和其他视觉障碍等眼部疾病。推动市场成长的关键因素包括眼部疾病盛行率的上升、技术进步和人口老化。
新冠疫情的影响
新冠疫情暂时扰乱了眼科诊断设备市场。患者就诊和择期手术被推迟,医疗资源被重新分配用于应对疫情。 2020年3月,美国眼科学会建议美国眼科医师暂停非紧急诊疗,导致病患就诊量大幅下降。供应链中断进一步影响了市场。然而,随着限制措施的放鬆,患者数量回升,择期手术恢復,自2021年以来,在人们对眼部健康的日益重视和眼部疾病患病率不断上升的推动下,市场呈现稳步增长。
市场驱动因素
眼部疾病的成长趋势:根据世界卫生组织(WHO,2023)的数据,全球约有22亿人患有视力障碍。老化、糖尿病和不健康的生活方式等因素正在增加眼部疾病的发生率。这一趋势推动了对诊断程序和先进眼科设备的需求。
技术进步:人工智慧 (AI) 整合到诊断设备中,提高了眼部疾病检测的准确性和效率。人工智慧应用,例如用于糖尿病视网膜病变的视网膜影像分析,有助于减轻眼科医师的负担并扩大筛检覆盖范围。远距眼科咨询和便携式设备正在扩大医疗服务的可近性,尤其是在偏远地区。
人口老化加剧:老年人口数量的增加,以及他们更容易患眼病,显着增加了对眼科诊断设备的需求。
市场限制因子
缺乏熟练的专业人员:训练有素的眼科技术人员数量有限,限制了市场成长。在美国,仅有不到 6 万名眼科技术人员为超过 1.9 万名眼科医师提供支援(2024 年美国眼科学会报告)。这种供需不平衡限制了先进设备的有效应用。
高成本和监管挑战:OCT 扫描器和眼底相机等先进设备价格昂贵。美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构的审批流程复杂,延缓了产品上市。
市场趋势
人工智慧整合和数位化:人工智慧驱动的诊断、远距眼科会诊和手持设备正在改变眼科产业。 IDx-DR 和Google的 ARDA 系统等创新技术实现了高效的即时诊断。
产品发布和策略联盟:各公司正透过合作、收购和技术升级来扩展其产品组合。例如,2023年11月,佳能医疗系统与克利夫兰诊所合作,共同改善眼科诊断的影像和IT技术。
依产品类型划分:
依最终使用者划分:
The global ophthalmic diagnostic devices market was valued at USD 2.72 billion in 2025 and is projected to grow to USD 2.89 billion in 2026, eventually reaching USD 4.82 billion by 2034, reflecting a CAGR of 6.60% during the forecast period. North America dominated the market in 2025 with a 38.20% share, driven by the high number of ophthalmic procedures, technological adoption, and new product launches. Key players in the market include Carl Zeiss Meditech AG, Topcon Corporation, NIDEK CO., LTD., Alcon Inc., EssilorLuxottica, Canon Medical Systems Corporation, Bausch + Lomb, Ziemer Ophthalmic Systems AG, Haag-Streit Group, and Visionix. These companies are focusing on technological innovations, strategic partnerships, and global expansions to strengthen their market presence.
Ophthalmic diagnostic devices include optical coherence tomography (OCT), aberrometer & topography systems, fundus cameras, ophthalmic ultrasound, slit lamps, ophthalmoscopes, and tonometers. These instruments are used for detecting, diagnosing, and monitoring ocular diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration, cataracts, refractive errors, and other vision impairments. The market growth is primarily driven by increasing prevalence of eye disorders, technological advancements, and the expanding geriatric population.
Impact of COVID-19
The COVID-19 pandemic temporarily disrupted the ophthalmic diagnostic devices market, as patient visits and elective procedures were postponed, and healthcare resources were redirected toward pandemic management. In March 2020, the American Academy of Ophthalmology advised U.S. ophthalmologists to halt non-urgent care, significantly reducing patient visits. Supply chain disruptions further impacted the market. However, as restrictions eased, patient volumes recovered, elective procedures resumed, and the market witnessed steady growth from 2021 onwards, driven by increasing awareness of eye health and a rising prevalence of ocular diseases.
Market Drivers
Rising Prevalence of Eye Disorders: According to the World Health Organization (2023), around 2.2 billion people worldwide suffer from vision impairment. Factors such as aging populations, diabetes, and unhealthy lifestyles are increasing the incidence of eye diseases. This trend drives demand for diagnostic procedures and advanced ophthalmic devices.
Technological Advancements: The integration of Artificial Intelligence (AI) in diagnostic devices improves the accuracy and efficiency of detecting ocular conditions. AI applications, like retinal image analysis for diabetic retinopathy, help reduce ophthalmologists' workload and increase screening coverage. Teleophthalmology and portable devices are expanding accessibility, especially in remote locations.
Growing Geriatric Population: The rising number of elderly individuals susceptible to eye disorders has significantly contributed to the demand for ophthalmic diagnostic devices.
Market Restraints
Shortage of Skilled Professionals: A limited number of trained ophthalmic technicians is restraining market growth. In the U.S., there are fewer than 60,000 ophthalmic technicians supporting over 19,000 ophthalmologists (2024 AAO report). This imbalance limits effective deployment of advanced devices.
High Cost and Regulatory Challenges: Advanced devices such as OCT scanners and fundus cameras are expensive. Regulatory approvals from authorities like the U.S. FDA and European Medicines Agency (EMA) involve complex procedures, which can delay market entry.
Market Trends
AI Integration and Digitalization: AI-driven diagnostics, teleophthalmology, and portable devices are transforming eye care. Innovations such as IDx-DR and Google's ARDA system facilitate efficient point-of-care diagnostics.
Product Launches and Strategic Collaborations: Companies are expanding product portfolios through partnerships, acquisitions, and technological upgrades. For example, in November 2023, Canon Medical Systems collaborated with Cleveland Clinic to improve imaging and IT technologies for ophthalmic diagnostics.
By Product Type:
By End-User:
Competitive Landscape
Key players include Carl Zeiss Meditech AG, Topcon Corporation, Alcon Inc., NIDEK CO., LTD., EssilorLuxottica, Canon Medical Systems, Bausch + Lomb, Ziemer Ophthalmic Systems, Haag-Streit Group, and Visionix. Strategies focus on product launches, global partnerships, and technological innovation. Recent developments include Bausch + Lomb's SeeNa system launch in 2024, Topcon Korea Medical expansion, and Visionix partnerships in Europe and North America.
Conclusion
The ophthalmic diagnostic devices market is projected to grow from USD 2.72 billion in 2025 to USD 4.82 billion by 2034, driven by technological innovation, AI integration, rising prevalence of eye disorders, and aging populations. Hospitals dominate the end-user segment, while OCT leads product type adoption. North America holds the largest market share, and Asia Pacific demonstrates the fastest growth. Strategic collaborations, innovative product launches, and digital solutions are expected to sustain market expansion, improving access to high-quality eye care globally.
Segmentation By Product Type, End-user, and Region
Segmentation By Product Type
By End-user
By Region